Investment
Features
FeesSafety
Academy
More
Pluang+

CryptoQuant warns Bitcoin correction possible as profits peak and US spot demand weakens.

Technical Signals
29 Sep 2026
Crypto Briefing
View Source
Neutral
CryptoQuant warns Bitcoin correction possible as profits peak and US spot demand weakens.

CryptoQuant highlights a surge in Bitcoin realized profits, reaching multi-month highs above 25,000 BTC daily, while US spot demand weakens, indicated by a negative Coinbase Premium Index. This mix suggests a potential near-term correction, echoing patterns from the 2022 downturn where speculative rallies faltered. Despite these signals, low exchange inflows and ongoing futures demand imply the market is in a "bullish cooldown" rather than a full bear market. Key indicators to watch include the Coinbase Premium Index, exchange inflows, and profit-taking velocity to gauge if any correction will be mild or severe.

Bitcoin correction potential is the story's subject, with Pluang market data providing context. Of 50 major cryptocurrencies, 15 rose and 34 fell today. Notable movers include CRV at Rp6.764 (+8.59%), EOS at Rp12.649 (+8.13%), and GRT at Rp524 (-6.21%). This snapshot is as of Sep 30, 2026 01:02 WIB.

More News

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...

Company Fundamentals
Bullish
22 minutes ago
Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...

Company Fundamentals
Bullish
2 hours ago
Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...

Analyst Insights
Bullish
3 hours ago
uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...

Market News
Bearish
3 hours ago
Silver Elephant Mining ups private placement to raise CAD 882K for working capital.

Silver Elephant Mining ups private placement to raise CAD 882K for working capital.

Silver Elephant Mining Corp. has increased its non-brokered private placement to 7.35 million units at CAD 0.12 each, aiming to raise up to CAD 882,000. Each unit includes one common share and one warrant to buy an additional share at CAD 0.16 within...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App